These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21590763)

  • 1. NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d.
    Kuylenstierna C; Björkström NK; Andersson SK; Sahlström P; Bosnjak L; Paquin-Proulx D; Malmberg KJ; Ljunggren HG; Moll M; Sandberg JK
    Eur J Immunol; 2011 Jul; 41(7):1913-23. PubMed ID: 21590763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.
    Joshi SK; Lang GA; Larabee JL; Devera TS; Aye LM; Shah HB; Ballard JD; Lang ML
    PLoS Pathog; 2009 Sep; 5(9):e1000588. PubMed ID: 19779559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function.
    Joshi SK; Lang ML
    Int Immunopharmacol; 2013 Oct; 17(2):260-6. PubMed ID: 23800654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
    Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
    Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of NK cell function driven by Vα24
    Iyoda T; Yamasaki S; Hidaka M; Kawano F; Abe Y; Suzuki K; Kadowaki N; Shimizu K; Fujii SI
    Clin Immunol; 2018 Feb; 187():76-84. PubMed ID: 29061445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.
    Gumperz JE; Miyake S; Yamamura T; Brenner MB
    J Exp Med; 2002 Mar; 195(5):625-36. PubMed ID: 11877485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
    Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
    Dasgupta S; Kumar V
    Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
    Maeda M; Shadeo A; MacFadyen AM; Takei F
    J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased invariant natural killer T-cell-mediated antitumor immune response in patients with gastric cancer.
    Ascui G; Gálvez-Jirón F; Kramm K; Schäfer C; Siña J; Pola V; Cristi F; Hernández C; Garrido-Tapia M; Pesce B; Bustamante M; Fluxá P; Molina MC; Ribeiro CH
    Immunol Cell Biol; 2020 Jul; 98(6):500-513. PubMed ID: 32189398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
    Pievani A; Borleri G; Pende D; Moretta L; Rambaldi A; Golay J; Introna M
    Blood; 2011 Sep; 118(12):3301-10. PubMed ID: 21821703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
    Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice.
    Liu Y; Teige A; Mondoc E; Ibrahim S; Holmdahl R; Issazadeh-Navikas S
    J Clin Invest; 2011 Jan; 121(1):249-64. PubMed ID: 21157037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease.
    Bonacini M; Soriano A; Zerbini A; Calò E; Cimino L; Muratore F; Fontana L; Braglia L; Parmeggiani M; Salvarani C; Croci S
    Front Immunol; 2018; 9():2157. PubMed ID: 30319620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1d-unrestricted NKT cells are endowed with a hybrid function far superior than that of iNKT cells.
    Farr AR; Wu W; Choi B; Cavalcoli JD; Laouar Y
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12841-6. PubMed ID: 25143585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a vascular endothelial cell-reactive type II NKT cell clone from a rat model of autoimmune vasculitis.
    Iinuma C; Waki M; Kawakami A; Yamaguchi M; Tomaru U; Sasaki N; Masuda S; Matsui Y; Iwasaki S; Baba T; Kasahara M; Yoshiki T; Paletta D; Herrmann T; Ishizu A
    Int Immunol; 2015 Feb; 27(2):105-14. PubMed ID: 25239132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
    East JE; Sun W; Webb TJ
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.